MyAverix Finance
HK · Healthcare
Lepu Biopharma Co Ltd (2157)
Biotechnology
Lepu Biopharma Co Ltd (2157) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $7.99B, P/E ratio is 26.06, net margin is 28.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2157
Lepu Biopharma Co Ltd (2157) — FAQ
What is Lepu Biopharma Co Ltd's market cap?
Lepu Biopharma Co Ltd (2157) has a reported market cap of $7.99B (data as of 2026-05-21).
What is 2157's P/E ratio?
The price-to-earnings (P/E) ratio for Lepu Biopharma Co Ltd (2157) is 26.06 (data as of 2026-05-21).
Does Lepu Biopharma Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Lepu Biopharma Co Ltd (2157). Check the MyAverix Finance app for the latest dividend data.
What sector is Lepu Biopharma Co Ltd in?
Lepu Biopharma Co Ltd (2157) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2157 listed on?
2157 is listed on HK.
What is Lepu Biopharma Co Ltd's net margin?
Lepu Biopharma Co Ltd (2157) reports a net margin of 28.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.